Orsted Biosciences

Striving for the best early-stage cancer tests

Learn more
UnRivaled Excellence

The colocalization on EVs that lead to the best results

EVs are the fingerprint of the cell. These are ultimately the best of many of our multiomic approaches for our early-stage cancer test.

Colocalization is the best conduit for early-stage cancer detection
Colocalization drastically increases specificity of a cancer test for a specific cancer type
EVs are plentiful
There are 10^10 EVs per mL of plasma
EVs are conserved
Eros elementum tristique. Duis cursus, mi quis.

This is how we work

We use strong theoretical and well-formed mathematical systems to optimize and continuously improve our early-cancer detection tests.
The Estimate

Lab space, reagents, chemicals, and samples

Requirements

We are going to create an early-stage lung and ovarian cancer tests that will beat everyone currently on the market and those trying to bring their tests onto the market.

Fine-Tuning

Strong mathematical modeling and fundamentally sound ideas are very important for reducing burn rate. However, as with all sound inventions, there is a need for small optimization tweaks. We will optimize the assay as needed to achieve unmatched results.

Product Launch

We plan on creating a test that is so good, doctors will have no choice but to give it to everyone who is aged 40 in the U.S.

1
The estimate

$10,000,000 Seed

2
Your requirements

Create early-stage lung and ovarian  cancer tests

3
Fine-tuning

Test and iteratively optimize on patient samples. Achieve FDA approval on an early-stage cancer  tests with 99% sensitivity and 99% specificity

4
Product launch!

Save millions of lives!

Drop us a line

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form

Office USA

170 Brookline Ave
Boston, MA 02215

Office Europe

Warsaw Poland

Contact us

1 (586) 707-3798

Mail us

crsedlak@umich.edu

Join us in our endeavor to eliminate cancer as a cause of death in the U.S

Get Started now